Evidence map›Paper›PMID 34858780›Full record

ArticleTranslational lung cancer research2021

Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.

Alberto Ruano-Ravina, Mariano Provencio, Virginia Calvo de Juan, Enric Carcereny, Anna Estival, Delvys Rodríguez-Abreu, Gretel Benítez, Rafael López-Castro, Marta Belver, María Guirado-Risueño and 15 more

Open access · diamondAbstract read
In one paragraph

Article in Translational lung cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  8. Review
  9. Article
  10. Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 12 institutions in 1 country.

Alberto Ruano-RavinaDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Mariano ProvencioDepartment of Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
Virginia Calvo de JuanDepartment of Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
Enric CarcerenyMedical Oncology Department, Catalan Institute of Oncology, Badalona- Germans Trias i Pujol Hospital B-ARGO group, Barcelona, Spain.
Anna EstivalMedical Oncology Department, Catalan Institute of Oncology, Badalona- Germans Trias i Pujol Hospital B-ARGO group, Barcelona, Spain.
Delvys Rodríguez-AbreuHospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Gretel BenítezHospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Rafael López-CastroServicio de Oncología, Sección de oncología médica, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Marta BelverServicio de Oncología, Sección de oncología médica, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
María Guirado-RisueñoHospital de Elche, Elche, Spain.
Carlos Guirao-RubioHospital de Elche, Elche, Spain.
Ana BlascoHospital General de Valencia, Valencia, Spain.
Bartomeu MassutíHospital Universitario General de Alicante, Alicante, Spain.
Ana Laura OrtegaServicio de Oncología Médica. Complejo Hospitalario de Jaén, Jaén, Spain.
Manuel CoboUnidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.
Joaquín Mosquera-MartínezHospital Universitario de A Coruña, A Coruña, Spain.
Carlos Aguado de la RosaDepartment of Oncology, Clínico San Carlos Hospital, Madrid, Spain.
Joaquim Bosch-BarreraGirona Biomedical Research Institute (IDIBGI), Girona, Spain.
Amparo Sánchez-GastaldoDepartment of Oncology, Hospital Virgen del Rocío, Seville, Spain.
Edel Del Barco MorilloDepartment of Oncology, Hospital de Salamanca, Slamanca, Spain.
Óscar JuanServicio Oncología Médica, Hospital Universitari i Politécnic La Fe, Valencia, Spain.
Manuel DómineHospital Jiménez Díaz, Madrid, Spain.
José Manuel TrigoServicio de Oncología Médica y Unidad de Fases I, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Diego Pereiro CorbachoHospital Universitario Álvaro Cunqueiro, Vigo, Spain.
Juana OramasHospital Universitario de Canarias, Santa Cruz Tenerife, Spain.
Universidade de Santiago de Compostela · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Clínico Universitario de Valladolid · ESHospital General Universitario de Elche · ESHospital Universitario Insular de Gran Canaria · ESInstitut Català d'Oncologia · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital General Universitario De Valencia · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Virgen del Rocío · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer causes approximately 25% of all cancer deaths. Despite its relevance, few studies have analyzed differences by sex at the time of diagnosis in terms of symptoms, stage, age or smoking status. We aim to assess if there are differences between men and women on these characteristics at diagnosis.

methodsWe analyzed the Thoracic Tumour Registry (TTR), sponsored by the Spanish Lung Cancer Group using a case-series design. This is a nationwide registry of lung cancer cases which started recruitment in 2016. For each case included, clinicians fulfilled an electronic record registering demographic data, symptoms, exposure to lung cancer risk factors, and treatment received in detail. We compared men and women using descriptive statistics.

resultsA total of 13,590 participants took part in this study, 25.6% women. Women were 4 years younger than men (64

conclusionsThere seems to be no differences in lung cancer characteristics by sex at the time at diagnosis on stage, specific symptoms or number of symptoms.

Indexed as

Lung neoplasmssexsmall cell lung cancer (SCLC)smokingsymptoms

Identifiers

PMID34858780
PMCPMC8577975
OpenAlexW3206168142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.